Fundz

Kneu Health raised $5.6M in Seed funding, co-led by Oxford Science Enterprises and Cedars-Sinai, to accelerate U.S. expansion and enhance Parkinson’s deployments.

PRIVATEOct 09, 2025

Amount Raised

$5.6 Million

Round Type

Seed

LondonBiotechnologyHealth Carehospital & health care

Investors

Cedars SinaiG. K. Goh VenturesSxsw LondonSocial Impact EnterprisesJimcoOxford Science Enterprises

Description

Kneu Health, based in London, UK, raised $5.6M in Seed funding. The round was co-led by Oxford Science Enterprises and Cedars-Sinai, with participation from several other investors. The company plans to use the funds for expanding commercial capacity and enhancing its neurological care platform. Kneu Health aims to improve deployments for Parkinson's and dementia monitoring.

Who else raised in hospital & health care and Biotechnology around the same time

Companies in the same sectors as Kneu Health that raised within 45 days of this round, from Fundz verified event records.

  • Self.co raised $3M (Seed) on November 11, 2025.
  • CustoMED raised $6M (Seed) on October 29, 2025.
  • Monsana raised $588K (Pre-Seed) on September 23, 2025.
  • Dectrocel raised $454K (Angel) on September 5, 2025.
  • Ultrahuman raised $11M (Debt Financing) on November 21, 2025.
  • BeyondSpring raised $2M (Funding Round) on November 21, 2025.

Who to call at Kneu Health, and when

A new round usually means Kneu Health is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kneu Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kneu Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kneu Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kneu Health

Location

London, England, United Kingdom

About

Kneu Health is a provider of a continuous intelligence for neurological care through smartphone-based monitoring of Parkinson’s and dementia. Built on Oxford University’s decade-long longitudinal research and validated across leading health systems, the company’s FDA-cleared platform transforms daily interactions into clinical insights that enable earlier intervention and personalized care. The company operates across eight NHS Trusts and flagship U.S. health systems.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kneu Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCaroline C., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kneu Health's next move

See what Strategic adds

Kneu Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.